Literature DB >> 12443798

Molecular typing of Plasmodium falciparum from Giemsa-stained blood smears confirms nosocomial malaria transmission.

K Kirchgatter1, G Wunderlich, M S Branquinho, T M Salles, Y C Lian, R A Carneiro-Junior, S M Di Santi.   

Abstract

In this report, we describe the partial molecular characterisation of Plasmodium falciparum isolates obtained from two individuals who were involved in a probable case of accidental malaria transmission after admission to a hospital in the metropolitan area of São Paulo, Brazil. Molecular analysis of polymorphic stretches of the merozoite surface protein 1 and 2 genes using PCR-typing and nucleotide sequencing revealed that the two isolates were identical and that the identified msp-1 gene was different from all others published to date. Additional anamnestic data supported our findings and made all other possible routes of infection unlikely. The methodology used here is simple to perform and needs as little as one Giemsa-stained blood smear as starting material.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12443798     DOI: 10.1016/s0001-706x(02)00181-x

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  3 in total

1.  Giemsa-stained thick blood films as a source of DNA for Plasmodium species-specific real-time PCR.

Authors:  Lieselotte Cnops; Marjan Van Esbroeck; Emmanuel Bottieau; Jan Jacobs
Journal:  Malar J       Date:  2010-12-22       Impact factor: 2.979

2.  Nosocomial Plasmodium falciparum infections confirmed by molecular typing in Medellín, Colombia.

Authors:  Lina González; Jesus Ochoa; Liliana Franco; Marta Arroyave; Eliana Restrepo; Silvia Blair; Amanda Maestre
Journal:  Malar J       Date:  2005-02-09       Impact factor: 2.979

3.  Malaysian child infected with Plasmodium vivax via blood transfusion: a case report.

Authors:  Claudia N Anthony; Yee-Ling Lau; Jia-Siang Sum; Mun-Yik Fong; Hany Ariffin; Wai-Linn Zaw; Indra Jeyajothi; Rohela Mahmud
Journal:  Malar J       Date:  2013-09-04       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.